Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Repertoire Immune Medicines
AddedFeb 13, 2024
UpdatedJun 18, 2026
Repertoire Immune Medicines

Repertoire Immune Medicines

US-based Repertoire Immune Medicines pioneers in clinical trials for cancer and autoimmune disease treatments.

HQ
Cambridge, MA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Repertoire Immune Medicines, founded in Cambridge, United States, is a clinical-stage biotechnology company dedicated to harnessing the human immune system to prevent, treat, or cure cancer, autoimmune conditions, and infectious diseases. The company focuses on discovering unique codes within the vast T cell repertoire and their interactions to develop transformative and programmable immune medicines. Currently, Repertoire is conducting experimental clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.

Notable affiliated individuals include leading scientists and clinicians in immunology and oncology. The company has attracted significant investment from prominent venture capital firms specializing in biotech innovations. Key achievements include advancing multiple candidates into clinical trials and pioneering novel approaches to immune system modulation. Repertoire Immune Medicines has made a substantial impact by pushing the boundaries of immunotherapy, aiming to deliver groundbreaking treatments for patients with severe diseases.

Repertoire Immune Medicines - Similar Companies

INmune Bio logo

INmune Bio

inmunebio.com

Inimmune logo

Inimmune

inimmune.com

Immunitas Therapeutics logo

Immunitas Therapeutics

immunitastx.com

Ernexa Therapeutics logo

Ernexa Therapeutics

eternatx.com

ImmuneBridge logo

ImmuneBridge

immunebridge.com

Immunome logo

Immunome

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

ImmunoMet Therapeutics logo

ImmunoMet Therapeutics

immunomet.com

ImmuneID logo

ImmuneID

Immuneering logo

Immuneering

immuneering.com

Immpact Bio logo

Immpact Bio

immpact-bio.com

ImmunityBio logo

ImmunityBio

immunitybio.com

GentiBio logo

GentiBio

gentibio.com

ImmuneSensor Therapeutics logo

ImmuneSensor Therapeutics

immunesensor.com

Triumvira Immunologics logo

Triumvira Immunologics

triumvira.com

Repertoire Immune Medicines - Quick Facts

Who are Repertoire Immune Medicines' competitors?

Companies similar to Repertoire Immune Medicines include INmune Bio, Inimmune, Immunitas Therapeutics and Ernexa Therapeutics.

When was Repertoire Immune Medicines founded?

Repertoire Immune Medicines was founded in 2015.

Where is Repertoire Immune Medicines' headquarters located?

Repertoire Immune Medicines' headquarters is located in Cambridge, MA, US.

When was Repertoire Immune Medicines' last funding round?

Repertoire Immune Medicines' most recent funding round was for $189M (USD) in April 2021.

How much has Repertoire Immune Medicines raised to-date?

As of Apr 13, 2021, Repertoire Immune Medicines has raised a total of $257.3M (USD).

How many employees does Repertoire Immune Medicines have?

Repertoire Immune Medicines has 175 employees as of Feb 4, 2024.

Repertoire Immune Medicines - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Immune Medicines
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified